Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 8 | 2024 | 415 | 2.940 |
Why?
|
| Neoplastic Stem Cells | 3 | 2024 | 99 | 1.710 |
Why?
|
| Carboplatin | 2 | 2024 | 20 | 1.070 |
Why?
|
| Omentum | 1 | 2024 | 5 | 0.870 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2024 | 81 | 0.830 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 131 | 0.800 |
Why?
|
| NF-kappa B | 3 | 2023 | 358 | 0.780 |
Why?
|
| Cell Line, Tumor | 11 | 2025 | 2676 | 0.770 |
Why?
|
| Phenotype | 2 | 2025 | 780 | 0.760 |
Why?
|
| Disease Progression | 1 | 2024 | 667 | 0.720 |
Why?
|
| Signal Transduction | 4 | 2024 | 2157 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2023 | 968 | 0.610 |
Why?
|
| Transcription Factor RelA | 2 | 2023 | 42 | 0.590 |
Why?
|
| Cell Proliferation | 3 | 2024 | 1455 | 0.570 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2018 | 4 | 0.570 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 31 | 0.560 |
Why?
|
| Retinal Dehydrogenase | 1 | 2017 | 10 | 0.550 |
Why?
|
| I-kappa B Kinase | 1 | 2018 | 51 | 0.540 |
Why?
|
| Isoenzymes | 1 | 2017 | 168 | 0.520 |
Why?
|
| Mice | 9 | 2025 | 6644 | 0.480 |
Why?
|
| Cell Culture Techniques | 2 | 2023 | 152 | 0.470 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 57 | 0.440 |
Why?
|
| Mice, Nude | 3 | 2024 | 408 | 0.420 |
Why?
|
| Muscle Proteins | 1 | 2010 | 51 | 0.320 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 154 | 0.320 |
Why?
|
| Sodium Channels | 1 | 2010 | 65 | 0.320 |
Why?
|
| Animals | 9 | 2025 | 16992 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 347 | 0.310 |
Why?
|
| Female | 11 | 2025 | 24698 | 0.300 |
Why?
|
| Neoplasms | 3 | 2025 | 1377 | 0.300 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 149 | 0.300 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 223 | 0.280 |
Why?
|
| Humans | 14 | 2025 | 43102 | 0.260 |
Why?
|
| Transcription Factor RelB | 2 | 2023 | 9 | 0.250 |
Why?
|
| Bystander Effect | 1 | 2025 | 15 | 0.230 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2025 | 13 | 0.230 |
Why?
|
| Tissue Scaffolds | 1 | 2025 | 35 | 0.220 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2024 | 28 | 0.210 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2023 | 2 | 0.210 |
Why?
|
| Adipocytes | 1 | 2024 | 60 | 0.210 |
Why?
|
| Gelatin | 1 | 2023 | 17 | 0.210 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 13 | 0.200 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 237 | 0.190 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2023 | 37 | 0.190 |
Why?
|
| Cell Survival | 3 | 2025 | 945 | 0.190 |
Why?
|
| Stem Cells | 1 | 2023 | 152 | 0.180 |
Why?
|
| Membrane Proteins | 1 | 2025 | 561 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2023 | 436 | 0.160 |
Why?
|
| Macrophages | 1 | 2024 | 529 | 0.160 |
Why?
|
| Mutation | 1 | 2025 | 1177 | 0.160 |
Why?
|
| RNA Interference | 1 | 2018 | 247 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 518 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1019 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2016 | 157 | 0.120 |
Why?
|
| Culture Media, Serum-Free | 1 | 2015 | 44 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 37 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 165 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 508 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 1723 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2015 | 638 | 0.090 |
Why?
|
| HT29 Cells | 1 | 2010 | 60 | 0.080 |
Why?
|
| Caco-2 Cells | 1 | 2010 | 64 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 290 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 934 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 592 | 0.070 |
Why?
|
| Cell Movement | 1 | 2010 | 655 | 0.060 |
Why?
|
| Glutarates | 1 | 2025 | 4 | 0.060 |
Why?
|
| Oncolytic Virotherapy | 1 | 2025 | 3 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2025 | 109 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2025 | 73 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2023 | 39 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2025 | 247 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 218 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2025 | 403 | 0.040 |
Why?
|
| Prognosis | 1 | 2023 | 861 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 129 | 0.030 |
Why?
|